Merck & Co – known as MSD outside of the US and Canada – has shared positive results from a late-stage trial of a Keytruda ...

Eli Lilly has announced a $3bn expansion to the US manufacturing facility that it acquired from Nexus Pharmaceuticals earlier ...

The National Institute for Health and Care Excellence (NICE) has recommended Santhera Pharmaceuticals’ Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD). The drug has been recommended ...

GSK and Duality Biologics have entered into an exclusive option agreement worth over $1bn for DualityBio’s preclinical ...

Merck & Co – known as MSD outside of the US and Canada – and Ridgeback Biotherapeutics have initiated a late-stage study to ...

We explore the various challenges facing orphan medicines entering the European market and offer solutions to help improve ...

Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of ...

Did you know we offer a suite of education and training options? Our workshops, insight sessions, and training help Pharma ...

Johnson & Johnson (J&J) has shared positive data from a late-stage study of its subcutaneous CD38-directed antibody Darzalex ...

EU Lab Day 2024 made an impact – reaching over 1.7million people through media and social. EatMoreFruit recently helped ...

Roche has shared new long-term results from a phase 3 study of its anti-CD79b antibody-drug conjugate Polivy (polatuzumab ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.